Show simple item record

dc.contributor.authorLoveday, C
dc.contributor.authorLaw, P
dc.contributor.authorLitchfield, K
dc.contributor.authorLevy, M
dc.contributor.authorHolroyd, A
dc.contributor.authorBroderick, P
dc.contributor.authorKote-Jarai, Z
dc.contributor.authorDunning, AM
dc.contributor.authorMuir, K
dc.contributor.authorPeto, J
dc.contributor.authorEeles, R
dc.contributor.authorEaston, DF
dc.contributor.authorDudakia, D
dc.contributor.authorOrr, N
dc.contributor.authorPashayan, N
dc.contributor.authorUK Testicular Cancer Collaboration, The PRACTICAL Consortium,
dc.contributor.authorReid, A
dc.contributor.authorHuddart, RA
dc.contributor.authorHoulston, RS
dc.contributor.authorTurnbull, C
dc.date.accessioned2018-07-18T13:17:13Z
dc.date.issued2018-09-01
dc.identifier.citationEuropean urology, 2018, 74 (3), pp. 248 - 252
dc.identifier.issn0302-2838
dc.identifier.urihttps://repository.icr.ac.uk/handle/internal/2089
dc.identifier.eissn1873-7560
dc.identifier.doi10.1016/j.eururo.2018.05.036
dc.description.abstractUNLABELLED: Testicular germ cell tumour (TGCT) is the most common cancer in young men. Multiplex TGCT families have been well reported and analyses of population cancer registries have demonstrated a four- to eightfold risk to male relatives of TGCT patients. Early linkage analysis and recent large-scale germline exome analysis in TGCT cases demonstrate absence of major high-penetrance TGCT susceptibility gene(s). Serial genome-wide association study analyses in sporadic TGCT have in total reported 49 independent risk loci. To date, it has not been demonstrated whether familial TGCT arises due to enrichment of the same common variants underpinning susceptibility to sporadic TGCT or is due to shared environmental/lifestyle factors or disparate rare genetic TGCT susceptibility factors. Here we present polygenic risk score analysis of 37 TGCT susceptibility single-nucleotide polymorphisms in 236 familial and 3931 sporadic TGCT cases, and 12 368 controls, which demonstrates clear enrichment for TGCT susceptibility alleles in familial compared to sporadic cases (p=0.0001), with the majority of familial cases (84-100%) being attributable to polygenic enrichment. These analyses reveal TGCT as the first rare malignancy of early adulthood in which familial clustering is driven by the aggregate effects of polygenic variation in the absence of a major high-penetrance susceptibility gene. PATIENT SUMMARY: To date, it has been unclear whether familial clusters of testicular germ cell tumour (TGCT) arise due to genetics or shared environmental or lifestyle factors. We present large-scale genetic analyses comparing 236 familial TGCT cases, 3931 isolated TGCT cases, and 12 368 controls. We show that familial TGCT is caused, at least in part, by presence of a higher dose of the same common genetic variants that cause susceptibility to TGCT in general.
dc.formatPrint-Electronic
dc.format.extent248 - 252
dc.languageeng
dc.language.isoeng
dc.publisherELSEVIER SCIENCE BV
dc.rights.urihttps://creativecommons.org/licenses/by/4.0
dc.subjectUK Testicular Cancer Collaboration, The PRACTICAL Consortium
dc.subjectHumans
dc.subjectNeoplasms, Germ Cell and Embryonal
dc.subjectTesticular Neoplasms
dc.subjectGenetic Predisposition to Disease
dc.subjectRisk Assessment
dc.subjectRisk Factors
dc.subjectCase-Control Studies
dc.subjectPedigree
dc.subjectLife Style
dc.subjectEnvironment
dc.subjectHeredity
dc.subjectMultifactorial Inheritance
dc.subjectPhenotype
dc.subjectPolymorphism, Single Nucleotide
dc.subjectMale
dc.subjectGenome-Wide Association Study
dc.subjectBiomarkers, Tumor
dc.titleLarge-scale Analysis Demonstrates Familial Testicular Cancer to have Polygenic Aetiology.
dc.typeJournal Article
dcterms.dateAccepted2018-05-31
rioxxterms.versionofrecord10.1016/j.eururo.2018.05.036
rioxxterms.licenseref.urihttps://creativecommons.org/licenses/by/4.0
rioxxterms.licenseref.startdate2018-09
rioxxterms.typeJournal Article/Review
dc.relation.isPartOfEuropean urology
pubs.issue3
pubs.notesNot known
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Complex Trait Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Predisposition & Translation Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular & Population Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.organisational-group/ICR
pubs.organisational-group/ICR/Primary Group
pubs.organisational-group/ICR/Primary Group/ICR Divisions
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Breast Cancer Research/Complex Trait Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Closed research teams/Predisposition & Translation Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Cancer Genomics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Genetics and Epidemiology/Oncogenetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Molecular Pathology/Molecular & Population Genetics
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Clinical Academic Radiotherapy (Huddart)
pubs.organisational-group/ICR/Primary Group/ICR Divisions/Radiotherapy and Imaging/Oncogenetics
pubs.publication-statusPublished
pubs.volume74
pubs.embargo.termsNot known
icr.researchteamComplex Trait Genetics
icr.researchteamPredisposition & Translation Genetics
icr.researchteamCancer Genomics
icr.researchteamMolecular & Population Genetics
icr.researchteamClinical Academic Radiotherapy (Huddart)
icr.researchteamOncogenetics
dc.contributor.icrauthorLaw, Philip
dc.contributor.icrauthorLitchfield, Kevin
dc.contributor.icrauthorBroderick, Peter
dc.contributor.icrauthorKote-Jarai, Zsofia
dc.contributor.icrauthorEeles, Rosalind
dc.contributor.icrauthorHuddart, Robert
dc.contributor.icrauthorHoulston, Richard
dc.contributor.icrauthorTurnbull, Clare


Files in this item

Thumbnail

This item appears in the following collection(s)

Show simple item record

https://creativecommons.org/licenses/by/4.0
Except where otherwise noted, this item's license is described as https://creativecommons.org/licenses/by/4.0